We serve Chemical Name:[(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate CAS:14682-46-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![[(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate](https://a.dearchem.com/CAS2/14682-46-3.png)
Chemical Name:[(3aS,5aS,6S,8R,8aR,9aR)-8-hydroxy-5,8-dimethyl-1-methylidene-2-oxo-5a,6,7,8a,9,9a-hexahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate
CAS.NO:14682-46-3
Synonyms:Cyaillardin;GAILLARDIN;Pleniradinacetat
Molecular Formula:C17H22O5
Molecular Weight:306.35400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:463.1ºC at 760mmHg
Density:1.23g/cm3
Index of Refraction:1.55
PSA:72.83000
Exact Mass:306.14700
LogP:1.75300
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Cyaillardin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pleniradinacetat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pleniradinacetat Use and application,GAILLARDIN technical grade,usp/ep/jp grade.
Related News: Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. 2′,5,6,7-tetrahydroxyflavone manufacturers As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. N-benzyl-4-cyano-5-[(2-ethylbutanoyl)amino]-N-isopropyl-3-methylthiophene-2-carboxamide suppliers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 3,6-di-O-acetyl-1,5-anhydro-2,4-di-O-methyl-D-glucitol vendor & factory.
